The Quality Management System (QMS) is being ever more important in PV and is an essential part of the PV system. This webinar will highlight the main points to consider and
17 Aug, 2016
26 Jul, 2016
Dr Seema Jaitly of Essjay Solutions is very pleased to be co-chairing the UK Pharmacovigilance Day 2016 on Tuesday 18th October in London. 2016 is expected to be an intriguing
20 Apr, 2016
The EU GVP modules have been in place for almost 4 years now and there have already been a couple of updates to individual modules. This webinar will briefly take you through
Dr. Seema Jaitly has been asked to present at the DIA India – International PV Conference in Mumbai, India which is running 13-14 May 2016. The theme is Innovations in
Seema Jaitly defines what constitutes a medication error and explains the process for accurate recording and reporting so that risks can be assessed and reduced. Download the
24 Feb, 2016
This webinar covers the legislation around device vigilance and helps you understand what needs to be reported and how this differs from reporting for medicinal products.
16 Feb, 2016
The latest MHRA Symposium was held on 6th November 2015 in London. Find out about all the latest updates the MHRA had and an overview of some of the presentations. This
With the updated EU legislation there are more definitive requirements for post authorisation safety studies. Understand the definitions and what your obligations are. This
Seema Jaitly, Managing Director of Essjay Solutions, has been asked to speak at the UK Pharmacovigilance Day in London on Monday 19th October. As pharmacovigilance rapidly
As the EU has started to monitor marketing literature, now is a good time to revisit your literature and ensure it is compliant for the regulators; this includes reviewing for
